Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've pressed the button, waited, and pulled the pen away — but there's still liquid visible in the KwikPen window. If you've spotted leftover Mounjaro in the pen after an injection, you're not alone; it's one of the questions our prescribers hear most weeks. The short answer is that a small amount of fluid remaining after a correctly administered dose is entirely normal and does not mean your dose was incomplete. The Mounjaro KwikPen is designed to hold a slight excess — what you see in the window is not medication you've missed; it's part of how the pen is engineered. That said, there are a few situations worth understanding, and tirzepatide as a weight-management medicine works best when doses are delivered consistently and correctly, so it's worth knowing what each scenario actually means.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture it: you've prepared your pen, found your site, pressed the button and held it for the full ten seconds as the instructions say. You pull the pen away and glance at the window. There's a sliver of liquid still visible. The instinct is to wonder whether the dose went in at all.
It did. The Mounjaro KwikPen is a multi-dose device (each pen contains four weekly doses) and Eli Lilly engineers each cartridge with a small overfill to ensure the correct volume reaches the needle tip every single time. What remains in the window after a properly completed injection is a combination of that overfill allowance and fluid that sits in the needle hub itself. According to the Mounjaro Summary of Product Characteristics on the eMC, the pen is calibrated to deliver the stated dose volume; residual liquid after use is expected and does not indicate an incomplete injection.
The most common misconception is that every drop of liquid in the cartridge must enter the body for the dose to count. It doesn't work that way. The pen's plunger moves a fixed, measured distance and no further. So long as you heard or felt the click, held the pen against the skin for the full ten seconds and saw the plunger move, your dose is almost certainly complete. Let that worry go.
Where it gets more interesting is when the window looks completely unchanged after pressing the button, that's a different situation and worth exploring below.
If the liquid level in the window looks virtually the same before and after you pressed the button, the dose may not have delivered fully. This is less common, but it does happen, and the cause is almost always technique or equipment rather than a defective pen.
First, check the needle. Mounjaro uses screw-on needles, and a needle that isn't attached tightly, or that was used for a previous injection, can block the flow entirely. Our guide to screw-on needles for Mounjaro walks through how to attach them correctly. A bent or blocked needle tip is often invisible to the eye but can stop the medication reaching the skin. Replacing the needle before every injection is not optional, it's the single most practical step for consistent delivery.
Second, the ten-second hold matters more than it sounds. Releasing the pen too quickly means the plunger hasn't completed its travel and some medication stays in the cartridge. Hold the pen firmly against the skin, button pressed, and count slowly to ten before removing it.
Third, skin folds and injection depth play a role. If the needle isn't fully inserted at a 90-degree angle, especially on thinner injection sites, some fluid can track back along the needle rather than disperse into tissue. Rotating between the abdomen, thigh and upper arm helps, as does gently pinching the skin if you're injecting on a leaner area.
If after checking all of this the window still isn't moving as expected, the NHS guidance on tirzepatide advises contacting your prescriber or pharmacist rather than attempting to re-inject. Don't try to use the same dose position twice in the same session.
Here is where clarity matters most. Each position in the KwikPen's four-dose cartridge is calibrated individually. Any residual fluid after a dose has been delivered (however much it looks like) is not a bonus dose sitting there waiting. It is a combination of manufacturing overfill, needle-pathway residue and, in some cases, medication that genuinely wasn't delivered if something went wrong with technique.
Attempting to draw on that residual liquid (whether by injecting a second time from the same dose position, by combining it with fluid from another pen or by any other means) is not safe. You have no way of knowing the exact volume remaining, and the pen is not designed to be used that way. The NHS tirzepatide patient information page is clear that each pen should be used as directed and that any unused medicine should be disposed of properly.
For disposal, used pens and detached needles should go into an approved sharps container rather than household bins. If you haven't got one, a 1-litre sharps container is straightforward to keep alongside your pens and is the correct way to handle used equipment.
If you're consistently finding that the window looks unchanged after injections, or you're uncertain whether your doses are landing properly, this is a practical question for your prescriber. It's not a trivial concern, dose consistency matters for how well tirzepatide works. If you notice there's still some Mounjaro left in the pen after your injection, our dedicated page explains what the different scenarios typically mean, and you can also find specific guidance on whether it's safe to use any leftover Mounjaro before deciding how to proceed. You can read more about what different amounts left in a Mounjaro pen usually mean if you want to understand specific scenarios in more detail.
One last detail that sometimes causes confusion: temperature. The KwikPen should be kept refrigerated at 2–8°C between doses. When you take it out of the fridge, you may notice the liquid looks slightly different in the window (occasionally a touch cloudier or with tiny bubbles) compared with when it went in. This is a normal result of the temperature change and, crucially, it can affect how the fluid level appears to the eye.
Always allow the pen to reach room temperature before injecting. Injecting cold medication from the fridge can be uncomfortable and may also affect how smoothly the plunger moves, which in turn changes how much appears to remain afterwards. The exact room-temperature window you can safely leave the pen out for is stated in the patient information leaflet inside your box, refer to that rather than any general estimate, because it is specific to your pen.
If you have questions about storage, technique or anything else about your treatment, the team on our contact page can connect you with aftercare support seven days a week. And if you're still exploring whether Mounjaro is right for you, understanding the cost context alongside the clinical picture is a reasonable place to start before booking a consultation. When you're ready, you can check your eligibility with our prescribers at any time.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.